1. Immunohistochemical and qPCR Detection of SARS-CoV-2 in the Human Middle Ear Versus the Nasal Cavity: Case Series
- Author
-
Adam S. DeConde, Kwang Pak, Arwa Kurabi, Allen F. Ryan, and Carol H. Yan
- Subjects
Nasal cavity ,Pathology ,medicine.medical_specialty ,Middle ear ,Ear, Middle ,Case Reports ,medicine.disease_cause ,Pathology and Forensic Medicine ,chemistry.chemical_compound ,otorhinolaryngologic diseases ,medicine ,Humans ,Coronavirus ,SARS-CoV-2 ,business.industry ,COVID-19 ,Epithelial cell adhesion molecule ,Immunohistochemistry ,Epithelium ,qPCR ,medicine.anatomical_structure ,Otitis ,Oncology ,Otorhinolaryngology ,chemistry ,Viral Receptor ,Angiotensin-Converting Enzyme 2 ,Nasal Cavity ,medicine.symptom ,business ,Viral load - Abstract
Viral infections have already been implicated with otitis media and sudden sensorineural hearing loss. However, the pathophysiology of COVID-19 as it relates to otologic disorders is not well-defined. With the spread of SARS-CoV-2, it is important to evaluate its colonization of middle ear mucosa. Middle ear and nasal tissue samples for quantitative RT-PCR and histologic evaluations were obtained from post-mortem COVID-19 patients and non-diseased control patients. Here we present evidence that SARS-CoV-2 colonizes the middle ear epithelium and co-localizes with the primary viral receptor, angiotensin-converting enzyme 2 (ACE2). Both middle ear and nasal epithelial cells show relatively high expression of ACE2, required for SARS-CoV-2 entry. The epithelial cell adhesion molecule (EpCAM) was use as a biomarker of epithelia. Furthermore, we found that the viral load in the middle ear is lower than that present in the nasal cavity.
- Published
- 2021
- Full Text
- View/download PDF